GHRP-6
Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Boxing as a sport activity associated with isolated GH deficiency.
Kelestimur. F F; Tanriverdi. F F; Atmaca. H H; Unluhizarci. K K; Selcuklu. A A; Casanueva. F F FF
Key Findings
- 45% of the boxers showed severe GH deficiency (peak GH < 10 ”g/L) after a GHRH+GHRPâ6 test.
- Mean peak GH in boxers (â11 ”g/L) was dramatically lower than in matched controls (â41 ”g/L).
- Boxers had significantly lower IGFâ1 levels than controls, indicating reduced overall GH activity.
- Peak GH levels were negatively correlated with both total years of boxing and number of bouts.
Practical Outcomes
- If you train in combat sports or have a history of head trauma, consider getting your GH axis checked, especially if you notice fatigue, poor recovery, or bodyâcomposition changes. The GHRPâ6âbased stimulation test can reveal hidden GH deficiency, but the study does not prescribe using GHRPâ6 as a therapy. Monitoring GH status may guide decisions about GHâsupporting strategies, such as lifestyle tweaks, protective headgear, or, under medical supervision, GHârelated interventions.
Summary
A small study found that male boxers often have a weak growth hormone (GH) response, likely because repeated blows to the head can damage the pituitary gland. When given a GHâstimulating test that includes GHRPâ6, boxers produced far less GH than healthy nonâboxers, and many had levels low enough to be called severe GH deficiency. Their IGFâ1 levels, a downstream marker of GH activity, were also lower. The longer someone boxed and the more fights they had, the lower their GH response tended to be.
Abstract
Traumatic brain injury (TBI) has long been known as a cause of hypopituitarism, and it is characterized by a high prevalence of neuroendocrine abnormalities. Boxing, one of the most common combative sports, may also result in TBI. As far as we know, pituitary functions including GH status have not been investigated in boxers. Therefore, in this preliminary study, we have assessed the pituitary functions in boxers. Eleven actively competing or retired male boxers with a mean age of 38.0 +/- 3.6 yr and 7 age-, sex- and BMI-matched healthy non-boxing controls were included in the study. Biochemical and basal hormonal parameters including IGF-I levels were measured. To assess GH secretory status in boxers and healthy controls, GHRH (1 microg/kg)+GHRP-6 (1 microg/kg) test was performed. After GHRH+GHRP-6 test, mean peak GH level in boxers and in controls were 10.9 +/- 1.7 and 41.4 +/- 6.7 microg/l, respectively (p < 0.05). Peak GH levels in 5 (45%) boxers were found to be lower than 10 microg/l and considered as severe GH deficient. In the control group, mean IGF-1 levels (367 +/- 18.8 ng/ml) were significantly higher than that obtained in boxers (237 +/- 23.3 ng/dl) (p < 0.01). All the other pituitary hormones were normal including ADH as no signs and symptoms of diabetes insipidus. There was a significant negative correlation between peak GH levels and boxing duration, and between peak GH levels and number of bouts. In conclusion, we think that boxing is a cause of TBI, and GH deficiency is very common among boxers. Further studies including large number of boxers, both professional and amateur, are needed to clarify pituitary dysfunction in boxers.
Study Information
pubmed
2004
10.1007/bf03345299